Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

275 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD); and the COVID-19 Global Rheumatology Allianc; Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for In… See abstract for full author list ➔ Izadi Z, et al. Among authors: cantagrel a. JAMA Netw Open. 2021 Oct 1;4(10):e2129639. doi: 10.1001/jamanetworkopen.2021.29639. JAMA Netw Open. 2021. PMID: 34661663 Free PMC article.
Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
Pavy S, Constantin A, Pham T, Gossec L, Maillefert JF, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, Wendling D, Dougados M. Pavy S, et al. Among authors: cantagrel a. Joint Bone Spine. 2006 Jul;73(4):388-95. doi: 10.1016/j.jbspin.2006.01.007. Epub 2006 Mar 23. Joint Bone Spine. 2006. PMID: 16626993
Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
Pham T, Gossec L, Constantin A, Pavy S, Bruckert E, Cantagrel A, Combe B, Flipo RM, Goupille P, Le Loët X, Mariette X, Puéchal X, Schaeverbeke T, Sibilia J, Tebib J, Wendling D, Dougados M. Pham T, et al. Among authors: cantagrel a. Joint Bone Spine. 2006 Jul;73(4):379-87. doi: 10.1016/j.jbspin.2006.01.014. Epub 2006 Mar 29. Joint Bone Spine. 2006. PMID: 16690341
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion.
Dernis E, Lavie F, Salliot C, Flipo RM, Saraux A, Maillefert JF, Paul C, Goupille P, Cantagrel A, Claudepierre P, Gaudin P, Tebib J, Wendling D, Schaeverbeke T, Le Loët X, Combe B. Dernis E, et al. Among authors: cantagrel a. Joint Bone Spine. 2009 Oct;76(5):524-31. doi: 10.1016/j.jbspin.2009.03.002. Epub 2009 May 19. Joint Bone Spine. 2009. PMID: 19457691
Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: development of recommendations for clinical practice based on published evidence and expert opinion.
Lavie F, Salliot C, Dernis E, Claudepierre P, Schaeverbeke T, Tebib J, Goupille P, Cantagrel A, Flipo RM, Gaudin P, Le Loët X, Maillefert JF, Paul C, Saraux A, Wendling D, Combe B. Lavie F, et al. Among authors: cantagrel a. Joint Bone Spine. 2009 Oct;76(5):540-6. doi: 10.1016/j.jbspin.2009.03.003. Epub 2009 May 19. Joint Bone Spine. 2009. PMID: 19457693
Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry.
Couderc M, Gottenberg JE, Mariette X, Pereira B, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Soubrier M; Club Rhumatismes et Inflammations. Couderc M, et al. Among authors: cantagrel a. Rheumatology (Oxford). 2014 Oct;53(10):1788-93. doi: 10.1093/rheumatology/keu176. Epub 2014 May 11. Rheumatology (Oxford). 2014. PMID: 24821852
Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry.
Lahaye C, Soubrier M, Mulliez A, Bardin T, Cantagrel A, Combe B, Dougados M, Flipo RM, Le Loët X, Shaeverbeke T, Ravaud P, Mariette X, Gottenberg JE; French Society of Rheumatology. Lahaye C, et al. Among authors: cantagrel a. Rheumatology (Oxford). 2016 May;55(5):874-82. doi: 10.1093/rheumatology/kev437. Epub 2016 Jan 27. Rheumatology (Oxford). 2016. PMID: 26822072
The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study.
Mariette X, Alten R, Nüßlein HG, Galeazzi M, Lorenz HM, Cantagrel A, Chartier M, Poncet C, Rauch C, Le Bars M. Mariette X, et al. Among authors: cantagrel a. Joint Bone Spine. 2017 Oct;84(5):571-576. doi: 10.1016/j.jbspin.2016.10.011. Epub 2016 Dec 30. Joint Bone Spine. 2017. PMID: 28043761 Free article.
275 results